Comparison of the Immune Profile of Nonhealing Cutaneous Leishmaniasis Patients with Those with Active Lesions and Those Who Have Recovered from Infection

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2000 Mar 18

PMID 10722561

Citations 44

Authors

S Ajdary

M H Alimohammadian

M B Eslami

K Kemp

A Kharazmi

Affiliations

Soon will be listed here.

Abstract

Th1-type cellular immune responses play a critical role in protection against infection with Leishmania parasites, whereas activation of Th2-type cells results in progressive disease. Cutaneous leishmaniasis caused by Leishmania major is often a self-healing disease; however, persistent nonhealing forms are also known. In the present study, we have described cell-mediated immune responses in nonhealing patients by measuring T-cell proliferation, cytokine production, and phenotypic characterization of these cells. The responses were compared with those of patients with active lesions, patients who had recovered from infection, and healthy controls. Peripheral blood mononuclear cells from patients with active lesions and recovered donors proliferated vigorously and produced Th1-type cytokine when stimulated with L. major antigens, whereas in nonhealing patients the proliferative responses were significantly lower and showed a Th2-type response to Leishmania antigens. Interleukin-10 (IL-10) production was not a feature of L. major stimulation. Flow cytometric analysis revealed that L. major antigen induced proliferation of the CD4-positive population and that these cells were the major source of gamma interferon and IL-4. These results show a distinct dichotomy in the cytokine response to L. major infection.

Citing Articles

Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis.

Parkash V, Ashwin H, Dey S, Sadlova J, Vojtkova B, Van Bocxlaer K Nat Med. 2024; 30(11):3150-3162.

PMID: 39095597 PMC: 11564116. DOI: 10.1038/s41591-024-03146-9.

A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection.

Naouar I, Kammoun Rebai W, Salah A, Bouguerra H, Toumi A, Hamida N PLoS Negl Trop Dis. 2023; 17(12):e0011784.

PMID: 38064516 PMC: 10732404. DOI: 10.1371/journal.pntd.0011784.

Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis.

de Lima S, Cavallone I, Serrano D, Anaya B, Lalatsa A, Laurenti M Pharmaceutics. 2023; 15(11).

PMID: 38004580 PMC: 10675550. DOI: 10.3390/pharmaceutics15112602.

A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.

Alimohmmadian M, Ajdary S, Bahrami F Iran Biomed J. 2022; 26(2):99-109.

PMID: 35090305 PMC: 8987415. DOI: 10.52547/ibj.26.2.99.

An Insight Into Systemic Immune Response in Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India.

Thakur L, Madaan P, Jain A, Shankar V, Negi A, Bhushan Chauhan S Front Immunol. 2022; 12:765684.

PMID: 35087516 PMC: 8787830. DOI: 10.3389/fimmu.2021.765684.

References

Javadian E, MESGHALI A . Studies on cutaneous leishmaniasis in Khuzestan, Iran. Part I. The leptomonad infection of sandflies. Bull Soc Pathol Exot Filiales. 1974; 67(5):513-6. View

Kemp K, Theander T, Hviid L, Garfar A, Kharazmi A, Kemp M . Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis. Scand J Immunol. 1999; 49(6):655-9. DOI: 10.1046/j.1365-3083.1999.00554.x. View

Scott P, Pearce E, Natovitz P, Sher A . Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J Immunol. 1987; 139(1):221-7. View

Nilsen R, Mshana R . In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis. Scand J Immunol. 1987; 26(5):503-12. DOI: 10.1111/j.1365-3083.1987.tb02284.x. View

Fiorentino D, Zlotnik A, Vieira P, Mosmann T, Howard M, Moore K . IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991; 146(10):3444-51. View

Mosmann T, Moore K . The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today. 1991; 12(3):A49-53. DOI: 10.1016/S0167-5699(05)80015-5. View

Scott P . IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol. 1991; 147(9):3149-55. View

Pirmez C, Yamamura M, Uyemura K, Conceicao-Silva F, Modlin R . Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest. 1993; 91(4):1390-5. PMC: 288111. DOI: 10.1172/JCI116341. View

Moore K, OGarra A, de Waal Malefyt R, Vieira P, Mosmann T . Interleukin-10. Annu Rev Immunol. 1993; 11:165-90. DOI: 10.1146/annurev.iy.11.040193.001121. View

10.

Ghalib H, Piuvezam M, Skeiky Y, Siddig M, Hashim F, El-Hassan A . Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest. 1993; 92(1):324-9. PMC: 293600. DOI: 10.1172/JCI116570. View

11.

Da-Cruz A, Conceicao-Silva F, Bertho A, Coutinho S . Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect Immun. 1994; 62(6):2614-8. PMC: 186553. DOI: 10.1128/iai.62.6.2614-2618.1994. View

12.

Kemp M, Hey A, Kurtzhals J, Christensen C, Gaafar A, Mustafa M . Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin Exp Immunol. 1994; 96(3):410-5. PMC: 1534571. DOI: 10.1111/j.1365-2249.1994.tb06043.x. View

13.

Kurtzhals J, Hey A, Jardim A, Kemp M, Schaefer K, Odera E . Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol. 1994; 96(3):416-21. PMC: 1534582. DOI: 10.1111/j.1365-2249.1994.tb06044.x. View

14.

Swihart K, Fruth U, Messmer N, Hug K, BEHIN R, Huang S . Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J Exp Med. 1995; 181(3):961-71. PMC: 2191906. DOI: 10.1084/jem.181.3.961. View

15.

Gaafar A, Kharazmi A, Ismail A, Kemp M, Hey A, Christensen C . Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections. Clin Exp Immunol. 1995; 100(2):239-45. PMC: 1534327. DOI: 10.1111/j.1365-2249.1995.tb03660.x. View

16.

Reiner S, Locksley R . The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995; 13:151-77. DOI: 10.1146/annurev.iy.13.040195.001055. View

17.

Kemp M, Theander T, Kharazmi A . The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today. 1996; 17(1):13-6. DOI: 10.1016/0167-5699(96)80562-7. View

18.

Bogdan C, Gessner A, Solbach W, Rollinghoff M . Invasion, control and persistence of Leishmania parasites. Curr Opin Immunol. 1996; 8(4):517-25. DOI: 10.1016/s0952-7915(96)80040-9. View

19.

Melby P, Darnell B, Valencia-Pacheco G . In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. FEMS Immunol Med Microbiol. 1996; 15(2-3):101-7. DOI: 10.1111/j.1574-695X.1996.tb00059.x. View

20.

Abbas A, Murphy K, Sher A . Functional diversity of helper T lymphocytes. Nature. 1996; 383(6603):787-93. DOI: 10.1038/383787a0. View